{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:48Z","timestamp":1794745188438,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG070873"],"award-info":[{"award-number":["R01AG070873"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008474","name":"New Jersey Commission on Brain Injury Research","doi-asserted-by":"publisher","award":["CBIR23IRG008"],"award-info":[{"award-number":["CBIR23IRG008"]}],"id":[{"id":"10.13039\/100008474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008474","name":"New Jersey Commission on Brain Injury Research","doi-asserted-by":"publisher","award":["CBIR25IRG005"],"award-info":[{"award-number":["CBIR25IRG005"]}],"id":[{"id":"10.13039\/100008474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119963","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:27:53Z","timestamp":1790915273000},"page":"119963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cyclic nucleotide signaling through phosphodiesterase 1 inhibition and its interaction with the competing endogenous RNA network regulates cognition"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7388-0899","authenticated-orcid":false,"given":"Fu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3355-1426","authenticated-orcid":false,"given":"Zhutao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baomin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-6508","authenticated-orcid":false,"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-7922","authenticated-orcid":false,"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119963_bib1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4103\/1673-5374.386406","article-title":"Amyloid-beta and tau protein beyond Alzheimer's disease","volume":"19","author":"Abyadeh","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","article-title":"Amyloid-beta and Tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay","volume":"17","author":"Abdulkhaliq","year":"2026","journal-title":"Cell. Death Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119963_bib3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/brain\/awaf382","article-title":"KIF2A downregulation links amyloid-beta to Tau phosphorylation in Alzheimer's disease","volume":"149","author":"Ruiz-Reig","year":"2026","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"18","key":"10.1016\/j.biopha.2026.119963_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813900","article-title":"Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies","volume":"24","author":"Buccellato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119963_bib6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119963_bib7","unstructured":"Shan, L., Radioiodinated (Z)-2-(4-(2-hydroxyethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one, in Molecular Imaging and Contrast Agent Database (MICAD). 2004: Bethesda (MD)."},{"key":"10.1016\/j.biopha.2026.119963_bib8","series-title":"Molecular Imaging and Contrast Agent Database (MICAD)","article-title":"Fluorinated and iodinated (Z)-2-(4-(2-fluoroethoxy)benzylidene)-5-iodobenzofuran-3(2H)-one","author":"Shan","year":"2004"},{"key":"10.1016\/j.biopha.2026.119963_bib9","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.2147\/IJN.S444115","article-title":"Current Anti-Amyloid-beta Therapy for Alzheimer's Disease Treatment: From Clinical Research to Nanomedicine","volume":"18","author":"Zhao","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.biopha.2026.119963_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.17219\/acem\/171379","article-title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease","volume":"32","author":"Kurkinen","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biopha.2026.119963_bib12","first-page":"699","article-title":"Approved drugs and natural products at clinical stages for treating Alzheimer's disease","volume":"22","author":"Ma","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119963_bib13","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s10787-025-01916-6","article-title":"Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease","volume":"33","author":"Wasim","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2026.119963_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.molmed.2024.10.006","article-title":"Promoting proteostasis by cAMP\/PKA and cGMP\/PKG","volume":"31","author":"Ahammed","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biopha.2026.119963_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112512","article-title":"The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (abeta) peptide","volume":"383","author":"Shekarian","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"1-3","key":"10.1016\/j.biopha.2026.119963_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.08.027","article-title":"Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor","volume":"620","author":"Deshmukh","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119963_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118796","article-title":"Cyclic nucleotide phosphodiesterase 1 and cognitive impairment: Mechanistic insights and therapeutic implications","volume":"193","author":"Li","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2026.119963_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.coph.2011.09.002","article-title":"PDE1 isozymes, key regulators of pathological vascular remodeling","volume":"11","author":"Chan","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2006.10.016","article-title":"The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4","volume":"168","author":"Brown","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2026.119963_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1070677","article-title":"The role of Phosphodiesterase-1 and its natural product inhibitors in Alzheimer's disease: A review","volume":"13","author":"Ahmad","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119963_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110822","article-title":"Phosphodiesterase inhibitors say NO to Alzheimer's disease","volume":"134","author":"Nabavi","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119963_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13543776.2022.2027910","article-title":"PDE1 inhibitors: a review of the recent patent literature (2008-present)","volume":"32","author":"Le","year":"2022","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2026.119963_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2019.103449","article-title":"Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses","volume":"102","author":"O'Brien","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119963_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41580-022-00534-2","article-title":"Genomic regulation of transcription and RNA processing by the multitasking Integrator complex","volume":"24","author":"Welsh","year":"2023","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119963_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.31083\/j.jin2206136","article-title":"Identification of a lncRNA\/circRNA-miRNA-mRNA ceRNA Network in Alzheimer's Disease","volume":"22","author":"Su","year":"2023","journal-title":"J. Integr. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2026.119963_bib26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1567205020666221130090103","article-title":"Construction of lncRNA-ceRNA Networks to Reveal the Potential Role of Lfng\/Notch1 Signaling Pathway in Alzheimer's Disease","volume":"19","author":"Yu","year":"2022","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.biopha.2026.119963_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biopha.2026.119963_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100158","article-title":"Ceria-nanocluster based therapy for Alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-beta deposition","author":"Liu","year":"2025","journal-title":"Cell. Biomater."},{"issue":"11","key":"10.1016\/j.biopha.2026.119963_bib29","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41386-018-0178-6","article-title":"Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice","volume":"43","author":"Zhang","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.biopha.2026.119963_bib30","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.1021\/acsomega.2c07951","article-title":"Antiamnesic Effects of Novel Phthalimide Derivatives in Scopolamine-Induced Memory Impairment in Mice: A Useful Therapy for Alzheimer's Disease","volume":"8","author":"Karim","year":"2023","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.biopha.2026.119963_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbr.2010.05.032","article-title":"Different effects of scopolamine on the retrieval of spatial memory and fear memory","volume":"221","author":"Huang","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2026.119963_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","article-title":"The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119963_bib33","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3162","article-title":"Assessing Spatial Working Memory Using the Spontaneous Alternation Y-maze Test in Aged Male Mice","volume":"9","author":"Prieur","year":"2019","journal-title":"Bio Protoc."},{"issue":"96","key":"10.1016\/j.biopha.2026.119963_bib34","doi-asserted-by":"crossref","DOI":"10.3791\/52434","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"53","key":"10.1016\/j.biopha.2026.119963_bib35","doi-asserted-by":"crossref","DOI":"10.3791\/2920","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","author":"Bromley-Brits","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"8","key":"10.1016\/j.biopha.2026.119963_bib36","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/brain\/awae127","article-title":"Leptin receptor reactivation restores brain function in early-life Lepr-deficient mice","volume":"147","author":"Fernandes","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119963_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102635","article-title":"Beyond the blur: Scopolamine's utility and limits in modeling cognitive disorders across sexes - Narrative review","volume":"104","author":"Jagielska","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2026.119963_bib38","article-title":"Mitochondrial dysfunction in Alzheimer's disease","volume":"107","author":"D'Alessandro","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s12967-023-04254-9","article-title":"Identification of mitochondrial related signature associated with immune microenvironment in Alzheimer's disease","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib40","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1038\/s41598-022-10554-9","article-title":"Transcriptome analysis of fasudil treatment in the APPswe\/PSEN1dE9 transgenic (APP\/PS1) mice model of Alzheimer's disease","volume":"12","author":"Yan","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119963_bib41","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1096\/fj.201801846R","article-title":"Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease","volume":"33","author":"Qian","year":"2019","journal-title":"FASEB J."},{"issue":"45","key":"10.1016\/j.biopha.2026.119963_bib42","doi-asserted-by":"crossref","first-page":"14919","DOI":"10.1523\/JNEUROSCI.1165-14.2014","article-title":"Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"issue":"9-10","key":"10.1016\/j.biopha.2026.119963_bib43","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s10495-024-01984-z","article-title":"The landscape of programmed cell death-related lncRNAs in Alzheimer's disease and Parkinson's disease","volume":"29","author":"Zhao","year":"2024","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00401-024-02787-x","article-title":"PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer's disease","volume":"148","author":"Schroder","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119963_bib45","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s11064-023-03944-6","article-title":"LncRNA NKILA Exacerbates Alzheimer's Disease Progression by Regulating the FOXA1-Mediated Transcription of TNFAIP1","volume":"48","author":"Zhou","year":"2023","journal-title":"Neurochem. Res."},{"issue":"8","key":"10.1016\/j.biopha.2026.119963_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biom15081188","article-title":"Apelin-13-Mediated Upregulation of METTL3 Ameliorates Alzheimer's Disease via Inhibiting Neuroinflammation Through m6A-Dependent Regulation of lncRNA BDNF-AS","volume":"15","author":"Han","year":"2025","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biopha.2026.119963_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18151","article-title":"Identification of key regulatory molecules in the early development stage of Alzheimer's disease","volume":"28","author":"Huang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119963_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/1567205017666200807185624","article-title":"LncRNA Xist, X-chromosome Instability and Alzheimer's Disease","volume":"17","author":"Chanda","year":"2020","journal-title":"Curr. Alzheimer Res."},{"issue":"8049","key":"10.1016\/j.biopha.2026.119963_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41586-024-08457-y","article-title":"The maternal X chromosome affects cognition and brain ageing in female mice","volume":"638","author":"Abdulai-Saiku","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119963_bib50","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.omtn.2021.04.010","article-title":"lncRNA Xist regulates sevoflurane-induced social and emotional impairment by modulating miR-98-5p\/EDEM1 signaling axis in neonatal mice","volume":"24","author":"Xu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12964-025-02534-z","article-title":"Xist in X chromosome inactivation: mechanisms and disease relevance","volume":"23","author":"Zhang","year":"2025","journal-title":"Cell. Commun. Signal."},{"issue":"2","key":"10.1016\/j.biopha.2026.119963_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cbin.11263","article-title":"Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124","volume":"44","author":"Yue","year":"2020","journal-title":"Cell. Biol. Int."},{"issue":"8","key":"10.1016\/j.biopha.2026.119963_bib53","first-page":"3915","article-title":"LncRNA XIST knockdown attenuates Abeta(25-35)-induced toxicity, oxidative stress, and apoptosis in primary cultured rat hippocampal neurons by targeting miR-132","volume":"11","author":"Wang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119963_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/01677063.2022.2028784","article-title":"lncRNA XIST induces Abeta accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer's disease","volume":"36","author":"Yan","year":"2022","journal-title":"J. Neurogenet."},{"issue":"6","key":"10.1016\/j.biopha.2026.119963_bib55","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s10787-022-01059-y","article-title":"Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats","volume":"30","author":"Bagri","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2026.119963_bib56","first-page":"1499","article-title":"The protective effect of taurine, piracetam and vinpocetine on etoposide-induced inflammation and brain injury in the serum of female albino rats","volume":"17","author":"Mohammed","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.biopha.2026.119963_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.alcohol.2022.08.005","article-title":"Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorder","volume":"105","author":"Sharma","year":"2022","journal-title":"Alcohol"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:00:12Z","timestamp":1794744012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S0753332226009996"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119963","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic nucleotide signaling through phosphodiesterase 1 inhibition and its interaction with the competing endogenous RNA network regulates cognition","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119963"}}